Elfabrio

migalastat · Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Elfabrio, covering 2023-05-09 to 2026-03-31. Get the full timeline:

Most recent: EMA Authorised: Elfabrio (pegunigalsidase alfa) — Chiesi Farmaceutici S.p.A